$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
吉非替尼使食管癌患者获益
2025-10-19 11:44:20
Check Details
吉非替尼治疗晚期食道癌
2025-10-19 11:44:20
Check Details
淋巴结对新辅助化疗的反应可以预测食管癌的预后
2025-10-19 11:44:20
Check Details
1期试验中首例食管癌患者注射NBTXR3
2025-10-19 11:44:20
Check Details
纳武单抗辅助疗法显著延长食道癌患者的无病生存期
2025-10-19 11:44:20
Check Details
纳武单抗联合化疗对治疗食管鳞癌比单药化疗更有效
2025-10-19 11:44:20
Check Details
FDA批准纳武单抗用于治疗术后食管/食管交界处癌
2025-10-19 11:44:20
Check Details
无病生存翻一倍!“O药”进军食管癌和GEJ癌
2025-10-19 11:44:20
Check Details
深入了解巴雷特食管,更好地预防食管癌
2025-10-19 11:44:20
Check Details
食管癌围术期治疗进展:O药成为辅助治疗标准方案
2025-10-19 11:44:20
Check Details
纳武单抗联合疗法一线治疗食管癌可延长患者的总生存期
2025-10-19 11:44:20
Check Details
食道癌术后常见并发症
2025-10-19 11:44:20
Check Details
1
2
...
245
246
247
248
249
250
251
...
4156
4157
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Inluriyo (Imlunestrant): Oral SERD for ER+/HER2- Breast Cancer with ESR1 Mutations
2
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies
3
Lorlatinib (Lorviqua): Oral Targeted Therapy for ALK-Positive Advanced Non-Small Cell Lung Cancer
4
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
5
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
6
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
7
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
8
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer
9
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
10
Vemurafenib (Zelboraf) Complete Medication Guide
11
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
12
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer